Drug-Induced Thrombotic Microangiopathy
- 1 January 2001
- journal article
- review article
- Published by Springer Science and Business Media LLC in Drug Safety
- Vol. 24 (7), 491-501
- https://doi.org/10.2165/00002018-200124070-00002
Abstract
No abstract availableKeywords
This publication has 110 references indexed in Scilit:
- Successful use of cyclosporine in a lung transplant recipient with tacrolimus-associated hemolytic uremic syndromeThe Journal of Heart and Lung Transplantation, 1999
- Thrombotic microangiopathy in a patient with chronic myelocytic leukaemia treated with α-interferonNephrology Dialysis Transplantation, 1999
- Bilateral nephrectomy stopped disease progression in plasma-resistant hemolytic uremic syndrome with neurological signs and comaKidney International, 1996
- THE SUCCESSFUL USE OF TACROLIMUS (FK506) IN A PANCREAS/KIDNEY TRANSPLANT RECIPIENT WITH RECURRENT CYCLOSPORINE-ASSOCIATED HEMOLYTIC UREMIC SYNDROMETransplantation, 1995
- FK 506 as an alternative in cyclosporin-induced hemolytic uremic syndrome in a kidney transplant recipientTransplant International, 1994
- A toxic interaction between mitomycin C and tamoxifen causing the haemolytic uraemic syndromeEuropean Journal of Cancer, 1993
- Acute Renal Failure during Therapy with Recombinant Human Gamma InterferonNew England Journal of Medicine, 1988
- Microangiopathic hemolytic anemia, a frequent complication of mitomycin therapy in cancer patientsEuropean Journal of Cancer and Clinical Oncology, 1984
- Acute Interstitial Nephritis with the Nephrotic Syndrome Following Recombinant Leukocyte A Interferon Therapy for Mycosis FungoidesNew England Journal of Medicine, 1984
- CYCLOSPORIN A TO PREVENT GRAFT-VERSUS-HOST DISEASE IN MAN AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATIONThe Lancet, 1980